logo
ResearchBunny Logo
The design and evaluation of hybrid controlled trials that leverage external data and randomization

Medicine and Health

The design and evaluation of hybrid controlled trials that leverage external data and randomization

S. Ventz, S. Khozin, et al.

This innovative research, conducted by a talented team including Steffen Ventz, Sean Khozin, and others, unveils a hybrid clinical trial design that melds external control datasets with randomization, optimizing treatment effect inference and addressing confounders in patient characteristics. Through simulations involving ES-SCLC and GBM studies, the study showcases the superiority of this approach over traditional trial methodologies.

00:00
00:00
Playback language: English
Abstract
This work introduces a hybrid clinical trial design combining external control datasets and randomization to improve the efficiency of treatment effect inference. The design accounts for potential confounders arising from differences in patient characteristics across studies. Simulations and datasets from extensive-stage small cell lung cancer (ES-SCLC) and glioblastoma (GBM) studies illustrate the advantages of this hybrid approach compared to externally controlled trials (ECTs) and randomized controlled trials (RCTs).
Publisher
Nature Communications
Published On
Oct 02, 2022
Authors
Steffen Ventz, Sean Khozin, Bill Louv, Jacob Sands, Patrick Y. Wen, Rifaquat Rahman, Leah Comment, Brian M. Alexander, Lorenzo Trippa
Tags
hybrid clinical trial design
external control datasets
treatment effect inference
confounders
ES-SCLC
GBM
clinical research
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny